Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ataxia | 7 | 2020 | 75 | 3.630 |
Why?
|
| Tremor | 7 | 2020 | 93 | 3.580 |
Why?
|
| Fragile X Syndrome | 8 | 2020 | 186 | 3.550 |
Why?
|
| Gait | 5 | 2020 | 381 | 1.260 |
Why?
|
| Accidental Falls | 3 | 2020 | 105 | 1.260 |
Why?
|
| Fragile X Mental Retardation Protein | 5 | 2016 | 112 | 1.250 |
Why?
|
| Postural Balance | 3 | 2021 | 103 | 1.240 |
Why?
|
| Heterozygote | 4 | 2020 | 88 | 1.110 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2020 | 119 | 1.080 |
Why?
|
| Walking Speed | 2 | 2020 | 34 | 0.780 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 155 | 0.770 |
Why?
|
| Databases, Factual | 2 | 2021 | 309 | 0.740 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2020 | 4 | 0.640 |
Why?
|
| Movement Disorders | 2 | 2020 | 57 | 0.640 |
Why?
|
| Nootropic Agents | 1 | 2020 | 11 | 0.640 |
Why?
|
| Attention | 1 | 2020 | 101 | 0.630 |
Why?
|
| Male | 16 | 2021 | 12438 | 0.630 |
Why?
|
| Huntington Disease | 1 | 2020 | 45 | 0.610 |
Why?
|
| Phenotype | 3 | 2016 | 260 | 0.610 |
Why?
|
| Female | 15 | 2021 | 12935 | 0.580 |
Why?
|
| Walking | 1 | 2020 | 232 | 0.570 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 800 | 0.560 |
Why?
|
| Executive Function | 1 | 2018 | 89 | 0.550 |
Why?
|
| Cyclodextrins | 1 | 2018 | 7 | 0.550 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2018 | 21 | 0.540 |
Why?
|
| Humans | 14 | 2021 | 22913 | 0.460 |
Why?
|
| Middle Aged | 8 | 2020 | 7895 | 0.450 |
Why?
|
| Aged | 7 | 2020 | 7429 | 0.440 |
Why?
|
| Receptors, Estrogen | 5 | 1995 | 62 | 0.420 |
Why?
|
| Hyperkinesis | 1 | 2013 | 8 | 0.410 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2013 | 17 | 0.410 |
Why?
|
| Cognition Disorders | 1 | 2018 | 692 | 0.410 |
Why?
|
| Adolescent | 4 | 2021 | 1877 | 0.400 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 865 | 0.350 |
Why?
|
| Child | 3 | 2021 | 1156 | 0.340 |
Why?
|
| Reference Values | 2 | 2021 | 169 | 0.330 |
Why?
|
| Adult | 5 | 2021 | 6912 | 0.330 |
Why?
|
| Walk Test | 2 | 2020 | 10 | 0.320 |
Why?
|
| Young Adult | 3 | 2021 | 1651 | 0.310 |
Why?
|
| Biomechanical Phenomena | 3 | 2016 | 537 | 0.300 |
Why?
|
| Child, Preschool | 2 | 2021 | 566 | 0.300 |
Why?
|
| Hippocampus | 4 | 1995 | 198 | 0.290 |
Why?
|
| Cognition | 2 | 2020 | 947 | 0.200 |
Why?
|
| Parkinson Disease | 2 | 2020 | 591 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2020 | 482 | 0.180 |
Why?
|
| Retrospective Studies | 2 | 2020 | 2994 | 0.170 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2020 | 4 | 0.160 |
Why?
|
| Time and Motion Studies | 1 | 2020 | 16 | 0.160 |
Why?
|
| Glucosylceramidase | 1 | 2020 | 13 | 0.160 |
Why?
|
| Foot | 1 | 2020 | 40 | 0.160 |
Why?
|
| Arm | 1 | 2020 | 68 | 0.150 |
Why?
|
| Range of Motion, Articular | 2 | 2020 | 564 | 0.150 |
Why?
|
| Animals | 7 | 2016 | 3293 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2020 | 370 | 0.150 |
Why?
|
| Mutation | 1 | 2020 | 328 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 3720 | 0.140 |
Why?
|
| Infusions, Spinal | 1 | 2018 | 5 | 0.140 |
Why?
|
| Motor Activity | 1 | 2020 | 267 | 0.140 |
Why?
|
| Spinal Puncture | 1 | 2018 | 23 | 0.140 |
Why?
|
| Brain Tissue Transplantation | 2 | 1993 | 15 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2016 | 30 | 0.130 |
Why?
|
| Time Factors | 1 | 2020 | 1263 | 0.120 |
Why?
|
| Posture | 1 | 2016 | 56 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2016 | 100 | 0.120 |
Why?
|
| Computers | 1 | 2015 | 14 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2015 | 50 | 0.120 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 42 | 0.120 |
Why?
|
| Cerebral Cortex | 2 | 1993 | 125 | 0.120 |
Why?
|
| Reaction Time | 1 | 2015 | 78 | 0.120 |
Why?
|
| Animals, Newborn | 3 | 1993 | 41 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 64 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2015 | 216 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2016 | 218 | 0.110 |
Why?
|
| Sexual Behavior, Animal | 1 | 1994 | 1 | 0.110 |
Why?
|
| Pituitary-Adrenal System | 1 | 1994 | 9 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 1994 | 26 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1994 | 21 | 0.110 |
Why?
|
| Arousal | 1 | 1994 | 48 | 0.110 |
Why?
|
| Disease Progression | 1 | 2016 | 522 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 1995 | 276 | 0.110 |
Why?
|
| Rats | 6 | 1995 | 627 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 43 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 356 | 0.100 |
Why?
|
| Cerebellar Diseases | 1 | 2013 | 8 | 0.100 |
Why?
|
| Movement | 1 | 2013 | 104 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 860 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2020 | 2940 | 0.090 |
Why?
|
| Neurons | 2 | 1995 | 273 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2016 | 1414 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 1020 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1995 | 315 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 2 | 1993 | 22 | 0.050 |
Why?
|
| Estradiol | 2 | 1993 | 52 | 0.050 |
Why?
|
| Pregnancy | 2 | 1993 | 324 | 0.040 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 1 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 7 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1995 | 10 | 0.030 |
Why?
|
| Sex Differentiation | 1 | 1995 | 2 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 18 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1995 | 24 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 43 | 0.030 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1994 | 7 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1994 | 5 | 0.030 |
Why?
|
| Aging | 2 | 1993 | 1101 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 25 | 0.030 |
Why?
|
| Gene Expression | 1 | 1995 | 176 | 0.030 |
Why?
|
| Cytosol | 2 | 1992 | 40 | 0.030 |
Why?
|
| Brain Mapping | 1 | 1994 | 123 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 1993 | 7 | 0.030 |
Why?
|
| Preoptic Area | 1 | 1993 | 5 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 1993 | 57 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 1994 | 232 | 0.030 |
Why?
|
| Age Factors | 1 | 1995 | 634 | 0.020 |
Why?
|
| Calcium | 1 | 1995 | 354 | 0.020 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 737 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 1990 | 1 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 3 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 1990 | 2 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 1990 | 3 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1990 | 70 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 176 | 0.020 |
Why?
|
| Sex Factors | 1 | 1990 | 384 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 1995 | 1 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1995 | 21 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 22 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 465 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 198 | 0.010 |
Why?
|